文献速递胸部肿瘤消化系统肿瘤

2021年欧洲癌症死亡率预测:聚焦胰腺癌与女性肺癌

European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer.
PubMed 文献 · Ann Oncol · 2021-02-21

研究基于世界卫生组织与Eurostat 1970-2015年数据,用joinpoint回归模型预测欧盟及五个人口大国加英国2021年癌症死亡数与年龄标化率。女性肺癌率仍上升6.5%达14.5/10万,胰腺癌两性模式稳定(男8.1/10万、女5.6/10万),仅年轻男性胰腺癌下降明显。

要点

  • 女性肺癌标化率仍上升6.5%至14.5/10万,男性肺癌继续下降。
  • 胰腺癌两性标化率稳定(男8.1/10万、女5.6/10万),仅年轻男性明显下降。

核心结论

  • 欧盟男女总体癌症死亡率继续下降,但胰腺癌仅在年轻男性中明显下降,需特别关注。
  • 烟草控制仍是预防胰腺癌及其他烟草相关癌症的优先事项,后者占欧盟癌症死亡的三分之一。

研究设计与样本

  • 基于世界卫生组织与Eurostat数据库1970-2015年癌症死亡证明和人口数据,预测欧盟及五个人口大国加英国2021年癌症死亡数与年龄标化率。
  • 使用joinpoint回归模型预测总癌症及10个主要部位2021年死亡数与年龄标化率(世界人口),并计算1989-2021年避免死亡数。

主要发现

  • 女性肺癌标化率仍上升6.5%至14.5/10万,男性肺癌率继续下降。
  • 欧盟乳腺癌预测标化率13.3/10万(降7.8%)。
  • 两性胃癌与白血病、男性膀胱癌标化率预测下降超过10%,其他部位趋势亦有利,但胰腺癌两性模式稳定(男8.1/10万、女5.6/10万)。
  • 欧盟25-49岁和50-64岁男性胰腺癌率分别下降10%和1.8%,65岁及以上男性上升1.3%,年轻女性仅下降3.4%。

临床怎么用

  • 提示临床与公共卫生应继续加强烟草控制,尤其关注女性烟草相关癌症趋势。
  • 胰腺癌整体死亡率未见明显下降,需重视早期筛查与诊疗研究,年轻男性下降趋势需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We predicted cancer mortality statistics for 2021 for the European Union (EU) and its five most populous countries plus the UK. We also focused on pancreatic cancer and female lung cancer. MATERIALS AND METHODS: We obtained cancer death certifications and population data from the World Health Organization and Eurostat databases for 1970-2015. We predicted numbers of deaths and age-standardised (world population) rates for 2021 for total cancers and 10 major cancer sites, using a joinpoint regression model. We calculated the number of avoided deaths over the period 1989-2021. RESULTS: We predicted 1 267 000 cancer deaths for 2021 in the EU, corresponding to age-standardised rates of 130.4/100 000 men (-6.6% since 2015) and 81.0/100 000 for women (-4.5%). We estimated further falls in male lung cancer rates, but still trending upward in women by +6.5%, reaching 14.5/100 000 in 2021. The breast cancer predicted rate in the EU was 13.3/100 000 (-7.8%). The rates for stomach and leukaemias in both sexes and for bladder in males are predicted to fall by >10%; trends for other cancer sites were also favourable, except for the pancreas, which showed stable patterns in both sexes, with predicted rates of 8.1/100 000 in men and 5.6/100 000 in women. Rates for pancreatic cancer in EU men aged 25-49 and 50-64 years declined, respectively, by 10% and 1.8%, while for those aged 65+ years increased by 1.3%. Rates fell for young women only (-3.4%). Over 1989-2021, about 5 million cancer deaths were avoided in the EU27 compared with peak rates in 1988. CONCLUSION: Overall cancer mortality continues to fall in both sexes. However, specific focus is needed on pancreatic cancer, which shows a sizeable decline for young men only. Tobacco control remains a priority for the prevention of pancreatic and other tobacco-related cancers, which account for one-third of the total EU cancer deaths, especially in women, who showed less favourable trends.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Carioli G, Malvezzi M, Bertuccio P, et al. European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer. Ann Oncol. 2021. PMID: 33626377. doi:10.1016/j.annonc.2021.01.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。